Ultrasound criteria to evaluate for early response to neoadjuvant chemotherapy in breast cancer

Ultrasound criteria to evaluate for early response to neoadjuvant chemotherapy in breast cancer - JABTS BC03

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000003478

Enrollment

150

Registered

2010-05-01

Start date

2010-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Interventions

None listed

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: The breast cancer patients for the neoadjuvant chemotherapy as primary systemic treatment.

Exclusion criteria

Exclusion criteria: No remarkable criteria

Design outcomes

Primary

Measure	Time frame
Ultrasound criteria to evaluate for early response to neoadjuvant chemotherapy in breast cancer was made. The rate of the responder and the non-responder in this criteria is compare to the rate pCR at surgery.	—

Secondary

Measure	Time frame
Quality control of the ultrasound criteria to evaluate for early response to neoadjuvant chemotherapy in breast cancer.	—

Countries

Japan

Outcome results